ctrl K

Watchlist Price Alert

Oncternal Therapeutics In... (ONCT)

NASDAQ: ONCT · Real-Time Price · USD

0.53

-0.16 (-23.63%)

At close: Dec 02, 2024, 9:00 PM

Oncternal Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	785K	1.49M	4.32M	3.38M	2.42M	2.52M	1.67M	-2.51M
Cost of Revenue	29.75M	179K	169K	12M	10.16M	46K	47K	2.51M
Gross Profit	-28.97M	1.31M	4.15M	-8.63M	-7.73M	2.48M	1.63M	-5.02M
Operating Income	-41.71M	-44.95M	-31.37M	-17.54M	-33.11M	-39.06M	-30.66M	-25.93M
Interest Income	2.23M	777K	33K	16K	188K	n/a	n/a	n/a
Pretax Income	-39.48M	-44.17M	-31.33M	-17.23M	-34.19M	-38.42M	-30.44M	-17.72M
Net Income	-39.48M	-43.39M	-31.3M	-17.21M	-15.91M	-38.42M	-30.44M	-17.72M
Selling & General & Admin	12.75M	13.46M	11.6M	8.37M	7.29M	9.39M	9.19M	8.71M
Research & Development	29.75M	32.98M	24.09M	12.54M	10.16M	29.67M	21.47M	17.23M
Other Expenses	-29.75M	-1.49M	-4.32M	-3.38M	-2.42M	641K	216K	46K
Operating Expenses	12.75M	44.95M	31.37M	17.54M	15.02M	39.06M	30.66M	25.93M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	200K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	42.5M	44.95M	31.37M	17.54M	15.02M	39.06M	30.66M	25.93M
Income Tax Expense	n/a	-777K	-33K	-16K	-18.28M	641K	-47K	-8.19M
Shares Outstanding (Basic)	2.94M	2.63M	2.47M	1.02M	516.45K	3.34M	2.49M	2.08M
Shares Outstanding (Diluted)	2.94M	2.63M	2.47M	1.02M	516.45K	3.34M	2.49M	2.08M
EPS (Basic)	-13.43	-16.5	-12.69	-16.95	-30.81	-11.52	-12.22	-8.52
EPS (Diluted)	-13.43	-16.5	-12.69	-16.95	-30.81	-11.52	-12.22	-8.52
EBITDA	2.23M	-44.95M	-31.37M	-17.54M	-33.11M	1.01M	-30.39M	-17.7M
EBIT	-39.48M	-44.17M	-31.33M	-17.54M	-34.19M	-6.58M	-30.44M	-17.72M
Depreciation & Amortization	41.71M	179K	169K	150K	15.02M	7.59M	47K	28K